Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised placebo-controlled trial

John R. Teerlink, Gad Cotter, Beth A. Davison, G. Michael Felker, Gerasimos Filippatos, Barry H. Greenberg, Piotr Ponikowski, Elaine Unemori, Adriaan A. Voors, Kirkwood F. Adams, Maria I. Dorobantu, Liliana R. Grinfeld, Guillaume Jondeau, Alon Marmor, Josep Masip, Peter S. Pang, Karl Werdan, Sam L. Teichman, Angelo Trapani, Christopher A. BushRajnish Saini, Christoph Schumacher, Thomas M. Severin, Marco Metra

Research output: Contribution to journalArticle

653 Scopus citations

Fingerprint Dive into the research topics of 'Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): A randomised placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences